Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Gains from Investment Securities: 2017-2024

Historic Gains from Investment Securities for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to -$1.5 million.

  • Bicycle Therapeutics' Gains from Investment Securities fell 24.84% to $233,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year decrease of 86.26%. This contributed to the annual value of -$1.5 million for FY2024, which is 137.30% down from last year.
  • Bicycle Therapeutics' Gains from Investment Securities amounted to -$1.5 million in FY2024, which was down 137.30% from $3.9 million recorded in FY2023.
  • Bicycle Therapeutics' Gains from Investment Securities' 5-year high stood at $13.8 million during FY2021, with a 5-year trough of -$1.5 million in FY2024.
  • For the 3-year period, Bicycle Therapeutics' Gains from Investment Securities averaged around $1.9 million, with its median value being $3.1 million (2022).
  • As far as peak fluctuations go, Bicycle Therapeutics' Gains from Investment Securities skyrocketed by 5,917.65% in 2021, and later plummeted by 137.30% in 2024.
  • Bicycle Therapeutics' Gains from Investment Securities (Yearly) stood at -$238,000 in 2020, then surged by 5,917.65% to $13.8 million in 2021, then tumbled by 77.47% to $3.1 million in 2022, then grew by 24.94% to $3.9 million in 2023, then slumped by 137.30% to -$1.5 million in 2024.